Why Israeli Hospitals Are Among the World's Best Clinical Validation Partners
A look at what makes Israel's clinical infrastructure uniquely suited for international healthcare companies seeking fast, structured validation environments.
Helping UK organisations engage with Israeli hospitals, clinical environments, defence innovation, and technology ecosystems - through senior-level relationships and proven cross-border execution.
A trusted strategic bridge between UK organisations and Israeli innovation - connecting healthcare companies, defence bodies, investors, and corporates with the right people, partners, and opportunities.
25+ years across technology commercialization, law, and international business development. Senior-level relationships on both sides, with a track record of real commercial outcomes.

Our primary focus is helping UK organisations access Israeli innovation, clinical environments, and strategic ecosystems. We also selectively support Israeli companies where there is strong UK alignment.
Our core service area - facilitating UK healthcare, medtech, digital health, and biotech companies in accessing Israeli hospitals, physicians, clinical environments, and innovation ecosystems.
Fostering direct relationships with relevant departments, principal investigators, and physician innovators within Israeli hospitals and health systems.
Enabling pilot collaborations and proof-of-concept programmes within Israeli clinical environments for early commercial validation.
Accessing real-world Israeli clinical environments for validation, testing, and early adopter partnerships.
Curated access to Israeli innovation ecosystems for UK venture capital funds, family offices, and strategic corporate investors - from targeted startup scouting to sustained ecosystem relationships.
Curated identification of Israeli companies aligned with your investment thesis - across healthcare, AI, deeptech, and advanced industries.
Facilitating direct access to founders and lead investors through senior-level relationships within the Israeli innovation ecosystem.
Identifying commercially relevant technologies from Israeli universities and hospital innovation environments.
Supporting UK corporates in identifying Israeli technology partners, innovation assets, and commercial opportunities - from technology scouting through to partnership execution.
Identifying and evaluating Israeli technology companies and innovation assets aligned with your strategic objectives.
Facilitating high-value partnerships with Israeli companies, universities, hospitals, and innovation organisations.
Facilitating R&D partnerships, technology licensing, and academic collaboration with leading Israeli research universities.
Supporting UK defence contractors, government bodies, and security organisations in accessing Israeli defence innovation — from dual-use technology scouting to institutional partnership facilitation.
Identifying Israeli defence and dual-use technology companies aligned with UK defence, security, and homeland security objectives.
Connecting UK defence contractors and government bodies with Israeli innovations spanning autonomous systems, cyber, sensing, and advanced materials.
Facilitating engagement between UK MOD-affiliated organisations and Israeli defence innovation ecosystem, including IMOD-linked entities and academic defence research.
We selectively engage with a limited number of Israeli companies where there is strong strategic alignment and a clear UK opportunity. This is not a mass-market offering.
Selective facilitation of partnerships with UK corporates, NHS bodies, and innovation organisations for Israeli companies with strong UK alignment.
Facilitating partnerships with UK venture capital, family offices, and strategic investors - for Israeli companies where there is clear strategic fit.
Israel offers UK healthcare companies and investors a uniquely accessible, sophisticated, and innovation-driven environment.
One of the most digitised healthcare systems in the world - with decades of longitudinal data, unified records, and innovation-friendly clinical infrastructure.
Israeli hospitals actively seek international partners for pilots and proof-of-concept collaborations - enabling faster clinical engagement cycles than most Western markets.
Globally recognised across AI, deeptech, and healthcare - Israel produces a disproportionate volume of breakthrough technologies relative to its size.
“Israel's combination of world-class clinical environments, digitised infrastructure, and innovation culture creates a uniquely compelling opportunity for UK healthcare and technology organisations.”
Discuss Clinical AccessEstablished relationships with Israeli hospitals, physicians, and innovation centres - fostering direct collaborations, not cold outreach.
Built on trusted, long-term institutional relationships on both sides. A strategic partner - not an intermediary or database service.
No account managers. No delegated teams. The founder is personally involved at every stage of every client relationship.
Judged on commercial outcomes - opening doors, facilitating real engagements, and supporting transactions through to completion.
Specialist cross-border advisory across the sectors where UK–Israel collaboration creates the most significant strategic and commercial value.
“Israel's innovation ecosystem and the UK's established commercial infrastructure create uniquely powerful cross-border opportunities.”
Discuss Your Practice AreaShort-form thinking on healthcare, defence, investment, and cross-border strategy.
A look at what makes Israel's clinical infrastructure uniquely suited for international healthcare companies seeking fast, structured validation environments.
How UK defence organisations are beginning to tap Israel's deep dual-use technology ecosystem, and what stands between intent and execution.
An assessment of current deal flow, ecosystem dynamics, and where UK investors are finding the most compelling Israeli opportunities in 2026.
We work with a select number of clients at any time - ensuring each engagement receives direct senior-level attention. We welcome enquiries from UK healthcare companies, defence organisations, investors, and corporates with a serious interest in Israeli ecosystems.